| Literature DB >> 32433566 |
Hadi Samadian1, Sina Zamiri2, Arian Ehterami3, Saeed Farzamfar4, Ahmad Vaez5, Hossein Khastar6, Mostafa Alam7, Armin Ai8, Hossein Derakhshankhah1, Zahra Allahyari9,10, Arash Goodarzi11, Majid Salehi12,13.
Abstract
Functional wound dressing with tailored physicochemical and biological properties is vital for diabetic foot ulcer (DFU) treatment. Our main objective in the current study was to fabricate Cellulose Acetate/Gelatin (CA/Gel) electrospun mat loaded with berberine (Beri) as the DFU-specific wound dressing. The wound healing efficacy of the fabricated dressings was evaluated in streptozotocin-induced diabetic rats. The results demonstrated an average nanofiber diameter of 502 ± 150 nm, and the tensile strength, contact angle, porosity, water vapor permeability and water uptake ratio of CA/Gel nanofibers were around 2.83 ± 0.08 MPa, 58.07 ± 2.35°, 78.17 ± 1.04%, 11.23 ± 1.05 mg/cm2/hr, and 12.78 ± 0.32%, respectively, while these values for CA/Gel/Beri nanofibers were 2.69 ± 0.05 MPa, 56.93 ± 1°, 76.17 ± 0.76%, 10.17 ± 0.21 mg/cm2/hr, and 14.37 ± 0.42%, respectively. The antibacterial evaluations demonstrated that the dressings exhibited potent antibacterial activity. The collagen density of 88.8 ± 6.7% and the angiogenesis score of 19.8 ± 3.8 obtained in the animal studies indicate a proper wound healing. These findings implied that the incorporation of berberine did not compromise the physical properties of dressing, while improving the biological activities. In conclusion, our results indicated that the prepared mat is a proper wound dressing for DFU management and treatment.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32433566 PMCID: PMC7239895 DOI: 10.1038/s41598-020-65268-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1SEM images of the electrospun (a) CA/Gel and (b) CA/Gel/Beri nanofibers.
Characteristic of the fabricated CA/Gel and CA/Gel/Beri nanofibers.
| Samples | Tensile strength (MPa) | Porosity (%) | Contact angle (°) | WVP mg/cm2/hr | Water uptake ratio (%) | Weight loss (%) | |
|---|---|---|---|---|---|---|---|
| Day 7 | Day 14 | ||||||
| CA/Gel/0% beri | 2.83 ± 0.08 | 78.17 ± 1.04 | 58.07 ± 2.35 | 11.23 ± 1.05* | 12.78 ± 0.32 | 38.0 ± 3.0 | 74.0 ± 5.0 |
| CA/Gel/1% beri | 2.69 ± 0.05 | 76.17 ± 0.76 | 56.93 ± 1 | 10.17 ± 0.21* | 14.37 ± 0.42 | 50.0 ± 3.0 | 79.0 ± 7.0 |
| Open container | 21.53 ± 0.42 | ||||||
*p < 0.05.
Abbreviations: CA: Cellulose acetate, Gel: Gelatin, beri: Berberine, WVP: Water vapor permeation.
Figure 2Microbial barrier property of the fabricated dressing after 3 and 7 days incubation, measured by colony counting assay. Values represent the mean ± SD, n = 3. *p < 0.05 in comparison with the positive control group (obtained by one-way ANOVA).
Figure 3Microbial barrier property of the fabricated dressing after 3 and 7 days incubation measured by Spectrophotometer at 600 nm. Values represent the mean ± SD, n = 3. *p < 0.05 in comparison with the positive control group (obtained by one-way ANOVA).
The antibacterial activities of the dressings evaluated by the time-kill assay (number of colony-forming units).
| Dressings | Minimum Inhibition Concentrations (MIC) | |||||||
|---|---|---|---|---|---|---|---|---|
| S.U-1h | S.U-2h | S.U-4h | S.U-24h | PS.a-1h | PS.a-2h | PS.a-4h | PS.a-24h | |
| Positive control | 22 ± 1.2 | 87 ± 5.5 | 201 ± 4.9 | 552 ± 9.1 | 21 ± 1.8 | 39 ± 3.1 | 83 ± 5.01 | 493 ± 6.6 |
| CA/Gel | 20 ± 2.5 | 72 ± 3.6 | 193 ± 7.16 | 499 ± 6.3 | 18 ± 0.2 | 33 ± 2.3 | 76 ± 4.7 | 460 ± 6.1 |
| CA/Gel/Beri | 17 ± 1.4 | 50 ± 2.9 | 78 ± 4.9 | 70 ± 3.7 | 16 ± 3.1 | 25 ± 3.06 | 31 ± 0.7 | 44 ± 5.7 |
Abbreviation: MIC: Minimum Inhibition Concentrations, S.U: Staphylococcus aureus, PS.a: Pseudomonas aeruginosa, CA: Cellulose acetate, Gel: Gelatin, beri: Berberine.
Figure 4Biocompatibility histogram of the fabricated dressings. (a) Hemocompatibility histogram. (b) Cell proliferation assay histogram measured by MTT assay after 24 and 72 h cell seeding. Values represent the mean ± SD, n = 3, *p < 0.05 in comparison with the positive control group (obtained by one-way ANOVA).
Figure 5The SEM micrograph of the cultured L929 murine fibroblastic cell on nanofibers after 24 h cell seeding.
Figure 6Haematoxylin and Eosin (H&E) and Masson’s trichrome (MT) stained microscopic sections of wounded tissue treated with dressings 16 days post-treatment. (a) The positive control, (b) the negative control, (c) the CA/Gel dressing, and (d) the CA/Gel/Beri dressing. Thick arrows: epidermal layer, thin arrows: infiltration of inflammatory cells, arrowheads rejuvenation of skin appendages, white arrows: neo-vascularization.
Histomorphometric analysis of different experimental groups.
| Groups | Collagen density (%) | Angiogenesis score | Epitheliogenesis Score (n = 4) |
|---|---|---|---|
| Negative control | 29.5 ± 2.3 | 9.3 ± 1.2 | 0,0,1,0 |
| CA/Gel | 71.7 ± 5.2 ** | 12.1 ± 2.7 | 3,2,2,3 * |
| CA/Gel/Beri | 88.8 ± 6.7*** | 19.8 ± 3.8** | 4,4,4,4 *** |
Values indicates treatment group versus un-treatment group (empty control); *P < 0.05, **P < 0.01, ***P < 0.001.
Abbreviations: CA: Cellulose acetate, Gel: Gelatin, beri: Berberine, WVP: Water vapor permeation.